Case report of mucormycosis in a diabetic patient after suffering a coronavirus infection
https://doi.org/10.62751/2713-0177-2025-6-1-10
Abstract
Mucormycosis is an aggressive fungal infection caused by fungi of the class Mucorales. It is rare, leading to diagnostic errors. Recently, cases of mucormycosis have been reported in the background of COVID-19. Our experience in the diagnosis and treatment of this disease, reflected in the presented clinical case, may be useful to endocrinologists and doctors of other specialties.
About the Authors
D. Sh. Аvzаlеtdinоvа
Bashkir State Medical University
Russian Federation
Russian Federation
Diana Sh. Аvzаlеtdinоvа – PhD (Med.), associate professor, endocrinologist of the Department of endocrinology
Ufa
O. U. Ibrаgimоvа
Bashkir State Medical University
Russian Federation
Russian Federation
Оlga U. Ibrаgimоvа – PhD (Med.), associate professor, endocrinologist of the Department of endocrinology
Ufa
A. Z. Bulgаkоvа
City Clinical Hospital No. 21
Russian Federation
Russian Federation
Аlfiya Z. Bulgаkоvа – endocrinologist, head of the Department of endocrinology
Ufa
References
1. Ferguson ВJ, Mitchell ТG, Moon R et al. Adjunctive hyperbaric oxygen for treatment of rhinocerebral mucormycosis. Rev Infect Dis. 1988; 10(3): 551–59. doi: 10.1093/clinids/10.3.551.
2. Ennis, David M. Serious infections in the diabetic. The Endocrinologist. 1996; 6(2): 95–97.
3. Safar A, Marsan J, Marglani O et al. Early identification of rhinocerebral mucormycosis. J Otolaryngol. 2005; 34(3): 166–71. doi: 10.2310/7070.2005.04023.
4. Андреев В.А.; Зачиняева А.В., Москалев А.В.. Медицинская микология. М.: ГЭОТАР-Медиа, 2008; 208 c. ISBN: 978-5-9704-0828-5.
5. Jankowski R, Nguyen DT, Poussel M et al. Sinusology. Eur Ann Otorhinolaryngol Head Neck Dis. 2016; 133(4): 263–68. doi: 10.1016/j.anorl.2016.05.011.
6. Kumari A, Rao NP, Patnaik U et al. Management outcomes of mucormycosis in COVID-19 patients: A preliminary report from a tertiary care hospital. Med J Armed Forces India. 2021; 77(Suppl 2): S289–95. doi: 10.1016/j.mjafi.2021.06.009.
7. Shakir M, Maan MHA, Waheed S. Mucormycosis in a patient with COVID-19 with uncontrolled diabetes. BMJ Case Rep. 2021; 14(7): e245343. doi: 10.1136/bcr-2021-245343.
8. Palejwala SK, Zangeneh TT, Goldstein SA, Lemole GM. An aggressive multidisciplinary approach reduces mortality in rhinocerebral mucormycosis. Surg Neurol Int. 2016; 7: 61. doi: 10.4103/2152-7806.182964.
9. Багирова Н.С. Инвазивный зигомикоз: эпидемиология и клинические особенности (обзор литературы). Клиническая онкогематология. 2016; 9(1): 84–89.
10. Древаль А.В., Губкина В.А., Камынина Т.С. с соавт. Три случая мукоромикоза у больных сахарным диабетом (Московская область). Проблемы эндокринологии. 2004; 50(5): 39–44. doi: 10.14341/probl11524.
11. Пялина О.О., Хостелиди С.Н., Зайцев В.А. с соавт. COVID-19-ассоциированные мукормикозы и инвазивный аспергиллез. Проблемы медицинской микологии. 2022; 24(2): 123.
Supplementary files
Review
For citations:
Аvzаlеtdinоvа D.Sh., Ibrаgimоvа O.U., Bulgаkоvа A.Z. Case report of mucormycosis in a diabetic patient after suffering a coronavirus infection. FOCUS. Endocrinology. 2025;6(1):75-78. (In Russ.) https://doi.org/10.62751/2713-0177-2025-6-1-10
Views:
60
Email this article 